To our knowledge, the diagnostic utility of IL-6 and IgA immunostaining to differentiate between lung lesions of PC-iMCD and IgG4-RD has not been adequately investigated. This evidence concerns the gene IL6 and immunoglobulin G4-related sclerosing disease.